Innoviva Company Insiders

INVA Stock  USD 17.41  0.14  0.80%   
Innoviva's insiders are aggressively buying. The analysis of insiders' sentiment of trading Innoviva stock suggests that vertually all insiders are extremely bullish at this time. Innoviva employs about 112 people. The company is managed by 4 executives with a total tenure of roughly 262 years, averaging almost 65.0 years of service per executive, having 28.0 employees per reported executive.

Innoviva's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-06-05Alexander J DennerAcquired 7000 @ 13.04View
2023-05-30Alexander J DennerAcquired 120000 @ 13.01View
2023-05-25Alexander J DennerAcquired 50000 @ 13.09View
2023-05-17Alexander J DennerAcquired 50000 @ 13.07View
2023-05-11Alexander J DennerAcquired 290000 @ 12.34View
2023-03-10Pavel RaifeldAcquired 3000 @ 10.87View
2022-03-31Innoviva, Inc.Acquired 5385208 @ 5View
2022-02-09Innoviva, Inc.Acquired 3614792 @ 5View
Monitoring Innoviva's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Innoviva's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Innoviva's future performance. Based on our forecasts, it is anticipated that Innoviva will maintain a workforce of about 250 employees by January 2025.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Innoviva Management Team Effectiveness

The company has return on total asset (ROA) of 0.0937 % which means that it generated a profit of $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0997 %, meaning that it created $0.0997 on every $100 dollars invested by stockholders. Innoviva's management efficiency ratios could be used to measure how well Innoviva manages its routine affairs as well as how well it operates its assets and liabilities. At present, Innoviva's Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Equity is forecasted to decline to 0.26. At present, Innoviva's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 944.3 M, whereas Other Assets are forecasted to decline to about 131.6 M.
The current year's Net Income Applicable To Common Shares is expected to grow to about 258.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 81.9 M.

Innoviva Workforce Comparison

Innoviva is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,154. Innoviva holds roughly 112 in number of employees claiming about 10% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.48 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.48.

Innoviva Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innoviva insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innoviva's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Innoviva insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
1.0
1
1
 300.00 
 976.00 
2024-06-01
3.0
12
4
 143,538 
 3,283 
2024-03-01
1.4286
10
7
 496,875 
 55,841 
2023-12-01
0.3333
1
3
 302.00 
 11,778 
2023-09-01
2.0
2
1
 210,000 
 785.00 
2023-06-01
27.0
27
1
 917,890 
 784.00 
2023-03-01
0.5
1
2
 3,000 
 4,352 
2022-12-01
1.0
1
1
 433.00 
 828.00 
2022-06-01
9.0
9
1
 229,775 
 828.00 
2022-03-01
1.0
1
1
 6,691 
 2,277 
2021-09-01
0.3333
1
3
 1,129 
 4,691 
2021-06-01
3.0
9
3
 224,892 
 32,256,019 
2021-03-01
2.0
4
2
 27,665 
 2,108 
2020-06-01
2.5
5
2
 84,585 
 1,205 
2020-03-01
0.6667
2
3
 24,475 
 6,576 
2019-09-01
1.0
1
1
 3,000 
 600.00 
2019-06-01
5.0
5
1
 81,995 
 601.00 
2019-03-01
2.0
6
3
 63,831 
 10,063 
2018-09-01
0.1667
1
6
 1,779 
 25,809 
2018-06-01
1.2
6
5
 85,494 
 29,480 
2018-03-01
0.8571
6
7
 273,495 
 80,344 
2017-12-01
0.1667
2
12
 29,026 
 117,286 
2017-06-01
0.8571
6
7
 119,142 
 34,739 
2017-03-01
0.8333
5
6
 813,727 
 47,440 
2016-12-01
0.3333
4
12
 197,152 
 37,006 
2016-06-01
0.8
4
5
 73,312 
 14,825 
2016-03-01
1.25
5
4
 657,368 
 35,978 
2015-06-01
1.2
6
5
 157,692 
 63,018 
2015-03-01
3.0
6
2
 519,989 
 13,578 
2014-09-01
0.7143
5
7
 408,890 
 137,450 
2014-06-01
7.1429
50
7
 1,506,509 
 176,601 
2014-03-01
0.4286
9
21
 253,150 
 318,388 
2013-12-01
0.25
1
4
 130,473 
 23,753 
2013-09-01
1.0
7
7
 3,114,157 
 70,305 
2013-06-01
0.88
22
25
 885,215 
 1,152,206 
2013-03-01
1.5
9
6
 167,037 
 33,732 
2012-12-01
1.0
8
8
 321,509 
 25,423 
2012-09-01
0.2941
5
17
 487,212 
 438,765 
2012-06-01
1.875
15
8
 10,135,225 
 112,558 
2012-03-01
1.75
7
4
 124,468 
 46,343 
2011-12-01
0.3333
3
9
 88,616 
 65,430 
2011-09-01
0.5
3
6
 9,507,190 
 9,413,513 
2011-06-01
1.4375
23
16
 480,580 
 429,906 
2011-03-01
0.6857
24
35
 1,652,904 
 1,537,114 
2010-12-01
1.5455
17
11
 5,950,446 
 135,517 
2010-09-01
0.125
1
8
 6,451 
 22,547 
2010-06-01
1.7
17
10
 158,708 
 145,455 
2010-03-01
1.2857
9
7
 224,960 
 40,545 
2009-12-01
0.125
1
8
 200,000 
 209,591 
2009-09-01
0.1111
1
9
 9,000 
 29,425 
2009-06-01
3.0
15
5
 109,000 
 6,753 
2009-03-01
1.0
5
5
 226,000 
 7,700 
2008-09-01
2.0
2
1
 90,000 
 34,676 
2008-06-01
0.6316
12
19
 90,898 
 39,800 
2007-12-01
0.15
3
20
 54,310 
 83,749 
2007-09-01
0.0706
6
85
 265,834 
 57,560 
2007-06-01
1.5
15
10
 429,435 
 54,598 
2006-06-01
0.2048
17
83
 297,234 
 101,187 
2005-12-01
3.5
7
2
 28,316 
 33,840 
2005-09-01
1.0
4
4
 59,000 
 59,000 

Innoviva Notable Stakeholders

An Innoviva stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Innoviva often face trade-offs trying to please all of them. Innoviva's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Innoviva's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pavel CFAChief OfficerProfile
Patricia DrakeI TherapeuticsProfile
Marianne CPAChief SecretaryProfile
Stephen MBAChief OfficerProfile

About Innoviva Management Performance

The success or failure of an entity such as Innoviva often depends on how effective the management is. Innoviva management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Innoviva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Innoviva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.18  0.19 
Return On Capital Employed 0.15  0.15 
Return On Assets 0.14  0.15 
Return On Equity 0.27  0.26 
Please note, the presentation of Innoviva's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Innoviva's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Innoviva's management manipulating its earnings.

Innoviva Workforce Analysis

Traditionally, organizations such as Innoviva use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Innoviva within its industry.

Innoviva Manpower Efficiency

Return on Innoviva Manpower

Revenue Per Employee2.8M
Revenue Per Executive77.6M
Net Income Per Employee1.6M
Net Income Per Executive44.9M
Working Capital Per Employee2.7M
Working Capital Per Executive76.5M

Complementary Tools for Innoviva Stock analysis

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm